Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: A cross-sectional study

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Røislien, Jo ^a,c   Van Calster, Ben ^b   Hjelmesæth, Jøran ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c VESTFOLD HOSPITAL TRUST   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D; BIOLOGICAL MARKER; PTH PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; DIET RESTRICTION; FEMALE; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; SEX DIFFERENCE; VITAMIN BLOOD LEVEL; BAYES THEOREM; BLOOD; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; MIDDLE AGED; NORWAY; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ADULT; BAYES THEOREM; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MAGNESIUM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NORWAY; OBESITY, MORBID; ODDS RATIO; PARATHYROID HORMONE; PHOSPHATES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; VITAMIN D;

EID: 79651475167     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-17     Document Type: Article

References (48)

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
2. James PT, Leach R, Kalamara E, Shayeghi M. The Worldwide Obesity Epidemic. Obesity 2001, 9:228S-233S.
3. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and Trends in Obesity Among US Adults, 1999-2000. JAMA 2002, 288:1723-1727. 10.1001/jama.288.14.1723, 12365955.
4. Haffner SM. The Metabolic Syndrome: Inflammation, Diabetes Mellitus, and Cardiovascular Disease. The American Journal of Cardiology 2006, 97:3-11. 10.1016/j.amjcard.2005.11.010, 16675316.
5. Wahba IM, Mak RH. Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology 2007, 2:550-562. 10.2215/CJN.04071206, 17699463.
6. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The Metabolic Syndrome: Prevalence and Associated Risk Factor Findings in the US Population From the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003, 163:427-436. 10.1001/archinte.163.4.427, 12588201.
7. Chiu KC, Chuang LM, Lee NP, Ryu JM, McGullam JL, Tsai GP, et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 2000, 49:1501-1505. 10.1053/meta.2000.17708, 11092519.
8. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005, 28:1228-1230. 10.2337/diacare.28.5.1228, 15855599.
9. Sun G, Vasdev S, Martin GR, Gadag V, Zhang H. Altered Calcium Homeostasis Is Correlated With Abnormalities of Fasting Serum Glucose, Insulin Resistance, and β-Cell Function in the Newfoundland Population. Diabetes 2005, 54:3336-3339. 10.2337/diabetes.54.11.3336, 16249463.
10. Guerrero-Romero F, Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetologica 2002, 39:209-213. 10.1007/s005920200036, 12486495.
11. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2007, 92:2017-2029. 10.1210/jc.2007-0298, 2085234, 17389701.
12. Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007, 30:1549-1555. 10.2337/dc06-2438, 17351276.
13. Reis JP, von Mühlen D, Miller ER. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. European Journal of Endocrinology J 2008, J:41-48.
14. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals. Diabetes Care 2009, 32:1278-1283. 10.2337/dc09-0209, 2699709, 19366976.
15. Hjelmesaeth J, Røislien J, Hofsø D, Bollerslev J. Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals. Diabetes Care 2010, 33:e13. 10.2337/dc09-1568, 20040663.
16. Lu L, Yu Z, Lin X. Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals. Diabetes Care 2010, 33:e14.
17. Hjelmesaeth J, Hofsø D, Aasheim E, Jenssen T, Moan J, Hager H, et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovascular Diabetology 2009, 8:7. 10.1186/1475-2840-8-7, 2644287, 19187564.
18. Rueda S, Fernandez-Fernandez C, Romero F, Martinez de OJ, Vidal J. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obesity Surgery 2008, 18:151-154. 10.1007/s11695-007-9352-3, 18175193.
19. Silver J, Kilav R, Naveh-Many T. Mechanisms of secondary hyperparathyroidism. American Journal of Physiology - Renal Physiology 2002, 283:F367-F376.
20. Moe SM. Disorders involving calcium, phosphorus, and magnesium. Primary Care; Clinics in Office Practice 35:215-237.
21. Bollen KA. Path Analysis 2005, John Wiley & Sons, Ltd.
22. World Medical Association declaration of Helsinki Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997, 277:925-926. 10.1001/jama.277.11.925, 9062334, World Medical Association declaration of Helsinki.
23. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32(Suppl 1):S62-S67. 2613584, 19118289, American Diabetes Association.
24. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1999, 159:2151-2159. 10.1001/archinte.159.18.2151, 10527292.
25. Kalaitzidis R, Tsimihodimos V, Bairaktari E, Siamopoulos KC, Elisaf M. Disturbances of Phosphate Metabolism: Another Feature of Metabolic Syndrome. American Journal of Kidney Diseases 2005, 45:851-858. 10.1053/j.ajkd.2005.01.005, 15861350.
26. Vyssoulis G, Karpanou E, Tzamou V, Kyvelou SM, Michaelidis A, Stefanadis C. Serum phosphate in white-coat hypertensive patients: focus on dipping status and metabolic syndrome. Hypertens Res 2010, 33:825-830. 10.1038/hr.2010.86, 20505672.
27. Gudmundsdottir H, Strand AH, Kjeldsen SE, Høieggen A, Os I. Serum Phosphate, Blood Pressure, and the Metabolic Syndrome -- 20-Year Follow-Up of Middle-Aged Men. The Journal of Clinical Hypertension 2008, 10:814-821. 10.1111/j.1751-7176.2008.00032.x, 19128269.
28. Reinehr T, de SG, Alexy U, Kersting M, Andler W. Vitamin D status and parathyroid hormone in obese children before and after weight loss. European Journal of Endocrinology J 2007, J:225-232.
29. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005, 294:2336-2341. 10.1001/jama.294.18.2336, 16278362.
30. Wood SN. Generalized additive models: An introduction with R 2006, Chapman & Hall/CRC.
31. Stage FK, Carter HC, Nora A. Path Analysis: An Introduction and Analysis of a Decade of Research. The Journal of Educational Research 2004, 98:5-12.
32. R Development Core Team R: A Language and Environment for Statistical Computing 2008, R Foundation for Statistical Computing, R Development Core Team.
33. Ntzoufras I. Bayesian modeling using WinBUGS 2009, Wiley.
34. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility. Statistics and Computing 2000, 10:325-337.
35. Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A. Bayesian measures of model complexity and fit. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 2002, 64:583-639.
36. Factor-Litvak P, Sher A. Invited Commentary: Coming Out of the Box. American Journal of Epidemiology 2009, 169:1179-1181. 10.1093/aje/kwp066, 19357325.
37. Chen W, Srinivasan SR, Berenson GS. Path Analysis of Metabolic Syndrome Components in Black Versus White Children, Adolescents, and Adults: The Bogalusa Heart Study. Annals of Epidemiology 2008, 18:85-91. 10.1016/j.annepidem.2007.07.090, 18191760.
38. Igna CV, Julkunen J, Vanhanen H. Anger expression styles and blood pressure: evidence for different pathways. Journal of Hypertension 2009, 27(10):1972-9. 10.1097/HJH.0b013e32832f4f8f, 19609221.
39. Sheehan LA, Macallan DC. Determinants of energy intake and energy expenditure in HIV and AIDS. Nutrition 2000, 16:101-106. 10.1016/S0899-9007(99)00245-2, 10696632.
40. Hjelmesæth J, Røislien J, Nordstrand N, Hofsø D, Hager H, Hartmann A. Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study. BMC Endocrine Disorders 2010, 10:6. 2861032, 20398422.
41. Regitz-Zagrosek V, Lehmkuhl E, Weickert M. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clinical Research in Cardiology 2006, 95:136-147. 10.1007/s00392-006-0351-5, 16598526.
42. Reis JP, von Mühlen D, Miller ER. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 2008, 159:41-48. 10.1530/EJE-08-0072, 18426812.
43. Jorde R, Svartberg J, Sundsfjord J. Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men. Journal of Hypertension 2005, 23:1639-1644. 10.1097/01.hjh.0000179764.40701.36, 16093907.
44. Haap M, Heller E, Thamer C, Tschritter O, Stefan N, Fritsche A. Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Eur J Clin Nutr 2006, 60:734-739. 10.1038/sj.ejcn.1602375, 16391583.
45. Congdon P. Applied Bayesian modelling 2003, Wiley.
46. Sturtz S, Ligges U, Gelman A. R2WinBUGS: A Package for Running WinBUGS from R. Journal of Statistical Software 2005, 12:1-16.
47. Gelfand AE, Sahu SK. Identifiability, Improper Priors, and Gibbs Sampling for Generalized Linear Models. Journal of the American Statistical Association 1999, 94:247-253.
48. Gelman A. Bayesian data analysis 2004, Chapman & Hall/CRC.